Biotech

All Articles

Rivus' stage 2 obesity-related cardiac arrest test attacks endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its fat-busting, muscle-sparing med...

Ovid standstills preclinical work, IV course after soticlestat fail

.Ovid Rehab currently revealed final month that it was actually trimming its own head count as the p...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has actually opened up a $700 thousand R&ampD facility in the Boston ma Port, improving i...

Boundless Bio helps make 'reasonable' unemployments 5 months after $100M IPO

.Only 5 months after protecting a $100 million IPO, Boundless Bio is actually giving up some staff m...

Halda's $126M will definitely evolve 'keep and kill' growth medications

.The preliminary phases of oncology R&ampD may not be short of appealing new techniques, and Halda T...

Lykos 'remorses' certainly not revealing research violations along with author

.Psychopharmacology has actually taken 3 short articles concerning midstage scientific trial data de...

Analysts dig into Avidity's DMD win, uncovering distinctions in records

.Avidity Biosciences amazed investors along with stage 1/2 records in Duchenne muscle dystrophy (DMD...

Actinogen's cortisol blocker falls short stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually overlooked the key endpoint of a period 2 researc...

Bivictrix chooses going exclusive only method to take ADC right into medical clinic

.Antibody-drug conjugates (ADCs) have gone to the center of many a billion-dollar biobuck licensing ...

TPG leadings up funds to $580M for financial investments throughout life scientific researches

.Possession supervisor TPG, which has supported biotechs such as Sionna Therapies and Santa Ana Bio,...